Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 30, 2026 06:13 ET | Source: Hofseth Biocare ASA

HOFSETH BIOCARE ASA: FIRST QUARTER 2026 FINANCIAL REPORT AND NEW COMMERCIAL UPDATE FOR CURRENT TRADING

Commercial update — second quarter 2026: Since the end of the first quarter, the Company has seen a very significant pick-up in commercial activity. Second-quarter top-line revenue is expected to be...
June 30, 2026 04:13 ET | Source: Zelluna ASA

Zelluna ASA awarded NOK 16 million Research Council of Norway grant

Oslo, 29 June 2026 – Zelluna (OSE: ZLNA), a company pioneering allogeneic "off-the-shelf" T Cell Receptor-based Natural Killer (TCR-NK) cell therapies for the treatment of solid cancers, today...
June 30, 2026 00:15 ET | Source: Questerre Energy Corporation

Questerre Preferred Shares commence trading on Euronext Growth

THIS NEWS RELEASE IS NOT FOR DISSEMINATION OR DISTRIBUTION IN THE UNITED STATES OF AMERICA TO UNITED STATES NEWSWIRE SERVICES OR UNITED STATES PERSONS CALGARY, Alberta, June 30, 2026 (GLOBE...
June 29, 2026 06:55 ET | Source: Rystad Energy AS

Rystad Energy launches Spektra: the next-generation market intelligence platform, shaped by the clients who use it

Rystad Energy launches Spektra, a new AI-native market intelligence platform built on 20+ years of proprietary energy data.
June 29, 2026 03:59 ET | Source: Zelluna ASA

Zelluna ASA: New share capital registered

Oslo, Norway, 29 June 2026: Reference is made to the stock exchange announcement published by Zelluna ASA (the “Company”) on 18 June 2026 regarding a successfully placed private placement (the...
June 29, 2026 02:30 ET | Source: Zelluna ASA

Zelluna ASA activates The Royal Marsden as second clinical site for ZIMA-101, expanding clinical execution capabilities

The Royal Marsden NHS Foundation Trust activated as the second clinical site in the ZIMA-101 Phase 1 trialPatient identification, pre-screening and screening activities ongoing at first activated...
June 26, 2026 10:40 ET | Source: Zelluna ASA

Readout from Legacy Ultimovacs DOVACC Phase II Trial Concludes UV1 Programme as Previously Guided

Oslo, 26 June 2026 – Zelluna (OSE: ZLNA), a company pioneering allogeneic "off-the-shelf" T Cell Receptor-based Natural Killer (TCR-NK) cell therapies for the treatment of solid cancers, today...
June 24, 2026 08:30 ET | Source: SEALSQ

SEALSQ Calls for Accelerated Post-Quantum Cryptography Migration Across Europe at IQT Nordics 2026

Geneva, Switzerland, June 24, 2026 (GLOBE NEWSWIRE) -- SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum...
June 24, 2026 08:30 ET | Source: Spectra Defense Technologies

Spectra Defense Technologies Unveils XSR Spire Ruggedized Mission Computer

ALPHARETTA, Ga., June 24, 2026 (GLOBE NEWSWIRE) -- Spectra Defense Technologies (Spectra) today launched XSR Spire, a rugged mission computer that delivers high-performance processing in a smaller,...
June 24, 2026 08:00 ET | Source: EQON

EQON Closes $6M Seed Round to Globally Scale Industrial Heating Cable Technology

STAVANGER, Norway, June 24, 2026 (GLOBE NEWSWIRE) -- EQON, a Norwegian technology company transforming industrial heating efficiency, today announced the close of a $6 million seed round to...